valproic acid

Generic: valproic acid

Labeler: upsher-smith laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name valproic acid
Generic Name valproic acid
Labeler upsher-smith laboratories, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

valproic acid 250 mg/1

Manufacturer
Upsher-Smith Laboratories, LLC

Identifiers & Regulatory

Product NDC 0832-0310
Product ID 0832-0310_39829040-e2d4-f4ca-e063-6394a90ace84
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA073229
Marketing Start 2011-10-29
Marketing End 2027-03-31

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc] mood stabilizer [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 08320310
Hyphenated Format 0832-0310

Supplemental Identifiers

RxCUI
1099681
UNII
614OI1Z5WI
NUI
N0000175753 N0000008486 N0000175751

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name valproic acid (source: ndc)
Generic Name valproic acid (source: ndc)
Application Number ANDA073229 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (0832-0310-11)
source: ndc

Packages (1)

0832-0310-11 100 CAPSULE in 1 BOTTLE (0832-0310-11)

Ingredients (1)

valproic acid (250 mg/1)

Linked Drug Pages (1)

valproic acid ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "39829040-e2d4-f4ca-e063-6394a90ace84", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751"], "unii": ["614OI1Z5WI"], "rxcui": ["1099681"], "spl_set_id": ["7d4df6ad-3d53-4664-9200-749487bf3689"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0832-0310-11)", "package_ndc": "0832-0310-11", "marketing_end_date": "20270331", "marketing_start_date": "20150209"}], "brand_name": "valproic acid", "product_id": "0832-0310_39829040-e2d4-f4ca-e063-6394a90ace84", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0832-0310", "generic_name": "valproic acid", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "valproic acid", "active_ingredients": [{"name": "VALPROIC ACID", "strength": "250 mg/1"}], "application_number": "ANDA073229", "marketing_category": "ANDA", "marketing_end_date": "20270331", "marketing_start_date": "20111029"}